Equinix, Inc. Investing Cash Flow increased by 46.2% to -$1.46B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 51.3%, from -$964.00M to -$1.46B. Over 4 years (FY 2021 to FY 2025), Investing Cash Flow shows a downward trend with a 21.2% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$728.73M | -$821.63M | -$820.70M | -$258.76M | -$1.37B | -$663.55M | -$1.07B | -$522.00M | -$669.00M | -$752.00M | -$1.28B | -$727.00M | -$734.00M | -$1.37B | -$1.11B | -$964.00M | -$1.44B | -$1.37B | -$2.71B | -$1.46B |
| QoQ Change | — | -12.7% | +0.1% | +68.5% | -429.1% | +51.5% | -61.5% | +51.3% | -28.2% | -12.4% | -70.3% | +43.2% | -1.0% | -86.0% | +18.6% | +13.2% | -49.4% | +4.9% | -97.8% | +46.2% |
| YoY Change | — | — | — | — | -87.9% | +19.2% | -30.6% | -101.7% | +51.1% | -13.3% | -19.5% | -39.3% | -9.7% | -81.5% | +13.3% | -32.6% | -96.2% | -0.4% | -143.9% | -51.3% |